Rizobacter is set to conquer the global soybean inoculant market

Rizobacter has already captured 23% of the market and is now focused on deepening biological fertilization in more than 40 countries. The company is among the five largest companies producing biological inputs in the world.

Rizobacter’s soy inoculants occupy 23 per cent of the global market share. Its production plant was born established 44 years ago and, from where here it deployed its an international expansion strategy, based mainly on establishing strong links with technical-scientific institutions, companies, and producers from other countries. The company assures that this allowed them to come up withcreate specific technologies, developed under strict international quality standards, which respond to the productive production needs of very dissimilar environments throughout America, Asia, Africa, and Europe. This positioning today places it among the five most important companies producing biological inputs at a global level.

Biological fixation can naturally provide up to 70% per cent of the nitrogen that the soybean plant needs during its development. The contribution of this biological process to the nutrition of the legume crop is maximized through the practice of inoculation. As a consequenceresult, the need for chemical fertilization is reduced, which representssaving a high economic cost for the producer and for the environment. Biological fixation, with allows reductions in the consumption of fossil fuels, a of high carbon emissions of carbon dioxide into the atmosphere, and an less impact on the balance of ecosystems.

Among the countries with the highest adoption ofwho have led adoption of this practice are Argentina, Brazil, Paraguay, Uruguay, Bolivia and, going to other latitudes, are Ukraine, France, Turkey, South Africa, and Canada. Due to the advantages that inoculants bring to the sustainable production of soybean cultivation, Rizobacter foresees a promising future regarding the adoption of this practicefor inoculation , which is still low in some countriesin an expanding number of additional countries.

Growth with a solid base

The demand for biological inputs has been growing; according to the latest record reports, it reached an annual increase of 14 per cent%. This pronounced shift from agricultural production towards sustainable technologies that bring sustainability to the systemin agriculture, finds Rizobacter well over its four decades invested in with more than four decades of research of inbiologics biological formulation technologies.  (Rizobacter commits 30% per cent of the of annual profits go tointo R&D programs). This trajectory is mainly reflected in the new formulations that add value to the traditional inoculants. The company has achieved developments linked to bacterial survival that today offer the possibility of performingability to apply seed treatments up to 220 days before planting. Also, with Osmo Protection Technology, it Rizobactger managed to strengthens bacteria and promotes their highest metabolic performance. Among the latest advances is the inclusion of bio-inductors capable of generating which generate molecular signals to accelerate communication between bacteria and plants; and bacteria that better tolerate water stress.

Matías Gorski, Rizobacter’s global manager of Biological Products, of the company explains on the basis for the company’s growth expectations are based. “These products are friendly to the environment, prevent soil degradation, are cheaper and safer for the producer, improve the quality and yields of crops, and inherently favor regenerative agriculture. At the same time, these advantages are combined with the greater regulatory demands of the countries that promote a reduction in the use of chemicals, and the demands of the consumers themselves for sustainable solutions.”

There are many challenges and opportunities.

In 2021, Rizobacter landed in Australia and Mexico, which join other recent countries such as Serbia, Croatia, Hungary, Malawi, Ghana, and Chile. In South Africa, for example, it already covers 60% per cent of the soy inoculants market.

Currently, its Rizobacter’s international presence amounts reaches to more than 40 countries where it seeks to expand its palette of biological products made up ofincluding biofungicides, bioinsecticides, biostimulants, and inoculants for various crops.